Description
Midostaurin, marketed under the brand name RYDAPT, It is an prescription medication that has been approved midostaurin (Rydapt) on April 28, 2017.
What is RYDAPT (midostaurin) ?
RYDAPT is a kinase inhibitor indicated for the treatment of adult patients with:
Newly diagnosed acute myeloid leukemia (AML) that is FLT3 mutationpositive as detected by an FDA-approved test, in combination with standard cytarabine and daunorubicin induction and cytarabine. RYDAPT is not indicated as a single-agent induction therapy for the treatment of patients with AML consolidation
Aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL).
How to order approved “RYDAPT (midostaurin) for capsules” Medicine?
RYDAPT (Midostaurin) Capsules is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing RYDAPT and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.
